RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Dahlia Biosciences

Dahlia Biosciences

Dahlia Biosciences offers premium RNA Flow Assays designed for researchers and scientists in the life sciences industry.

Website: dahliabio.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Medical.
Based in: San Francisco, United States.
Domain age: 9 years.
On Recent Funding since: Oct 11, 2026.
About Dahlia Biosciences

Discover our range of products and solutions today.

Dahlia Biosciences is a company based in San Francisco, United States. Recent Funding lists it under Health and bio. It went through IndieBio (IndieBio SF 06). Investors on record for it include SOSV and SOSV SF & NY (Fka IndieBio). It was founded by Un Kwon, Brad Taft, Michael Lin and 1 other.

Funding rounds

  1. IndieBio SF 06
    IIndieBio · batch
    Source: indiebio.co
  2. Website created

Founders and team

Investors

Similar Health and bio companies

Questions and sources

Dahlia Biosciences: questions and answers

Who invested in Dahlia Biosciences?
Investors on record for Dahlia Biosciences: IndieBio, SOSV and SOSV SF & NY (Fka IndieBio).
Who founded Dahlia Biosciences?
Dahlia Biosciences was founded by Un Kwon (Co-Founder & CEO), Brad Taft (Co-Founder & CSO), Michael Lin and Samuel Sternberg.
Where is Dahlia Biosciences based?
Dahlia Biosciences is based in San Francisco, United States.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/dahlia-biosciences (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy